Skip to content

APOTHEEK DELPLANCKE

Active
Private limited companyfounded 1991active for 35 yearsGrote Markt(D) 4, 8600 Diksmuide, BelgiumKBO/BCE: BE 0443.834.188

From the official registers: KBO 34 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK DELPLANCKE has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €915,492 and a net result of €140,953. Equity has been stable since 2018 (±1.3% per year). Its solvency ranks better than 91% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 04-04-1991 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.052.578.297 8600 Diksmuide, since 29-04-1991
Financial year end
31 December
Peppol
Reachable since 10-01-2025

Board and ownership

Board
  • DelapharmaDirector · since 01-04-2009 · permanent representative Victor Delplancke

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€243,415
▲ 3.8%
Turnover
≈ €1.1m
estimated
Profit
€140,953
▲ 9.9%
Equity
€915,492
▲ 18.2%
Total assets
€1.1m
▲ 12.2%
Filed on 18-05-2026, 74 days before the deadlinePDF
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 5.11, cash €312,705Equity €915,492 (82.8% of total assets)Founded in 1991Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 82% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 82.8% of total assets
Liquidity 84+16
short-term debt 11.8% · cash 28.3%
Profitability 85=
return on assets 12.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025highest value 06-2025: < 0.1%▼ -0.1 percentage points vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €85,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.11 (3.97 in 2024), above the usual 1.5. Short-term debt is 11.8% and cash 28.3% of total assets. 17.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 87% on liquidity, 79% on profitability and 71% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 5.11, cash €312,705
NBB · annual accounts
lowers risk · Equity €915,492 (82.8% of total assets)
NBB · annual accounts
lowers risk · Founded in 1991
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €915,492
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-05-2026, 74 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
74 days early
2024
72 days early
2023
30 days late
2022
47 days early
2021
61 days early
2020
54 days early
2019
65 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 49 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 May (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 90% of companies in retail tradesector median 36.6% · 12,757 companies 82.8% View
  • Positive: 8 profitable years in a rowprofit 2025: €140,953 8 years View

Comparable companies

These companies have the same main activity as APOTHEEK DELPLANCKE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.2m, founded between 1987 and 1992.

CompanyTotal assetsGross margin
APOTHEEK DELPLANCKE Diksmuide€1.1m€0.2m
apotheek de plaats Menen€1.1m€0.3m
LB Farma Kasterlee€1.1m€0.2m
Van der Vennet Apotheek Gent€1.1m€0.3m
Pharmacie des Blommes Mouscron€1.1m€0.3m
PHARMA PLUS Boussu€1.0m€0.2m
APOTHEEK DE BRABANDERE Schaarbeek€1.2m€0.2m
Full comparison

Documents

Annual accounts at the NBB

All 34 annual accounts

Articles and registers

Key facts about APOTHEEK DELPLANCKE

What is the company number of APOTHEEK DELPLANCKE?
The company number of APOTHEEK DELPLANCKE is 0443.834.188. The VAT number is the same number with BE in front: BE 0443.834.188.
Where is APOTHEEK DELPLANCKE based?
The registered office is at Grote Markt(D) 4, 8600 Diksmuide.Company details
What does APOTHEEK DELPLANCKE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK DELPLANCKE?
The legal form of APOTHEEK DELPLANCKE is Private limited company (BV).
When was APOTHEEK DELPLANCKE founded?
APOTHEEK DELPLANCKE was founded on 04-04-1991.
Is APOTHEEK DELPLANCKE still active?
Yes, APOTHEEK DELPLANCKE is an active enterprise in the KBO register.
How many employees does APOTHEEK DELPLANCKE have?
APOTHEEK DELPLANCKE had an average of 1.3 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK DELPLANCKE?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €243,415 and 51 comparable companies (NACE 477). It probably lies between €770,000 and €2.2m.
Is APOTHEEK DELPLANCKE profitable?
In financial year 2025, APOTHEEK DELPLANCKE made a profit of €140,953.
Where can I find the annual accounts of APOTHEEK DELPLANCKE?
APOTHEEK DELPLANCKE filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of APOTHEEK DELPLANCKE due?
APOTHEEK DELPLANCKE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.